Association between IGF1 CA microsatellites and mammographic density, anthropometric measures, and circulating IGF-I levels in premenopausal Caucasian women

Breast Cancer Research and Treatment

Volumn 116, Issue 2, 2009, Pages 413-423

  Fehringer, Gordon ^a,b   Ozcelik, Hilmi ^c,d   Knight, Julia A ^a,c   Paterson, Andrew D ^a,e   Boyd, Norman F ^f  

^a UNIVERSITY OF TORONTO   (Canada)

^b Cancer Care Ontario   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Anthropometric; Insulin like growth factor I; Mammographic density; Microsatellite; Polymorphism

Indexed keywords

MICROSATELLITE DNA; SOMATOMEDIN C;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; ANTHROPOMETRY; ARTICLE; BODY DENSITY; BODY FAT; BODY MASS; BREAST CANCER; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PREMENOPAUSE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL;

ADULT; ANTHROPOMETRY; BODY COMPOSITION; BREAST; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LINKAGE DISEQUILIBRIUM; MAMMOGRAPHY; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREMENOPAUSE; RADIOIMMUNOASSAY; RISK FACTORS;

EID: 67649238255     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0146-7     Document Type: Article

References (45)

1. Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ et al (2005) Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6(10):798-808. doi:10.1016/S1470-2045(05)70390-9
2. Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MR et al (2002) Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 347(12):886-
3. doi:10.1056/NEJMoa013390
4. Diorio C, Pollak M, Byrne C, Masse B, Hebert-Croteau N, YaffeM et al (2005) Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Cancer Epidemiol Biomarkers Prev 14(5):1065-1073. doi:10.1158/1055-9965.EPI-04-0706
5. Maskarinec G, Williams AE, Kaaks R (2003) A cross-sectional investigation of breast density and insulin-like growth factor I. Int J Cancer 107(6):991-996. doi:10.1002/ijc.11505
6. Boyd NF, Stone J, Martin LJ, Jong R, Fishell E, Yaffe M et al (2002) The association of breast mitogens with mammographic densities. Br J Cancer 87(8):876-882. doi:10.1038/sj.bjc.6600537
7. Byrne C, Colditz GA, Willett WC, Speizer FE, Pollak M, Hankinson SE (2000) Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res 60(14):3744-3748
8. Maskarinec G, Takata Y, Chen Z, Gram IT, Nagata C, Pagano I et al (2007) IGF-I and mammographic density in four geographic locations: a pooled analysis. Int J Cancer 121(8):1786-1792. doi:10.1002/ijc.22834
9. Verheus M, Peeters PH, Kaaks R, van Noord PA, Grobbee DE, van Gils CH (2007) Premenopausal insulin-like growth factor-I serum levels and changes in breast density over menopause. Cancer Epidemiol Biomarkers Prev 16(3):451-457. doi:10.1158/ 1055-9965.EPI-06-0642
10. dos Santos Silva I, Johnson N, De Stavola B, Torres-Mejia G, Fletcher O, Allen DS et al (2006) The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women. Cancer Epidemiol Biomarkers Prev 15(3):449-455. doi:10.1158/1055-9965.EPI-05-0555
11. Lai JH, Vesprini D, Zhang W, Yaffe MJ, Pollak M, Narod SA (2004) A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density. Cancer Epidemiol Biomarkers Prev 13(4):573-582
12. Harrela M, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J et al (1996) Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest 98(11):2612-2615. doi:10.1172/JCI119081
13. Hong Y, Pedersen N, Brismar K, Hall K, de Faire U (1996) Quantitative genetic analyses of insulin-like growth factor I (IGFI), IGF-binding protein-1, and insulin levels in middle-aged and elderly twins. J Clin Endocrinol Metab 81(5):1791-1797. doi:10.1210/jc.81.5.1791
14. Cleveland RJ, Gammon MD, Edmiston SN, Teitelbaum SL, Britton JA, Terry MB et al (2005) IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project. Carcinogenesis 27(4):758-765. doi:10.1093/carcin/bgi294
15. Wagner K, Hemminki K, Israelsson E, Grzybowska E, Soderberg M, Pamula J et al (2005) Polymorphisms in the IGF-1 and IGFBP 3 promoter and the risk of breast cancer. Breast Cancer Res Treat 92(2):133-140. doi:10.1007/s10549-005- 2417-x
16. Wen W, Gao YT, Shu XO, Yu H, Cai Q, Smith JR et al (2005) Insulin-like growth factor-I gene polymorphism and breast cancer risk in Chinese women. Int J Cancer 113(2):307-311. doi:10.1002/ijc.20571
17. DeLellis K, Ingles S, Kolonel L, McKean-Cowdin R, Henderson B, Stanczyk F et al (2003) IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort. Br J Cancer 88(2):277-282. doi:10.1038/sj.bjc.6600728
18. Figer A, Karasik YP, Baruch RG, Chetrit A, Papa MZ, Sade RB et al (2002) Insulin-like growth factor I polymorphism and breast cancer risk in Jewish women. Isr Med Assoc J 4(10):759-762
19. Missmer SA, Haiman CA, Hunter DJ, Willett WC, Colditz GA, Speizer FE et al (2002) A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer. Int J Cancer 100(3):332-336. doi:10.1002/ijc.10473
20. Yu H, Li BD, Smith M, Shi R, Berkel HJ, Kato I (2001) Polymorphic CA repeats in the IGF-I gene and breast cancer. Breast Cancer Res Treat 70(2):117-122. doi:10.1023/A:1012947027213
21. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ (1994) The quantitative analysis of mammographic densities. Phys Med Biol 39(10):1629-1638. doi:10.1088/0031-9155/39/10/008
22. Wang L, Hirayasu K, Ishizawa M, Kobayashi Y (1994) Purification of genomic DNA from human whole blood by isopropanolfractionation with concentrated Nal and SDS. Nucleic Acids Res 22(9):1774-1775. doi:10.1093/nar/22.9.1774
23. The Centre for Applied Genomics (2003) Hospital for Sick Children, Toronto. http://www.tcag.ca
24. Guo SW, Thompson EA (1992) Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48(2):361-372. doi:10.2307/2532296
25. Liu K, Muse SV (2005) PowerMarker: an integrated analysis environment for genetic marker analysis. Bioinformatics 21(9):2128-2129
26. SAS Institute Inc (1999-2001) SAS release 8.02 (1999-2001). SAS Institute Inc, Cary
27. Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG (2002) Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 53(2):79-91. doi:10.1159/ 000057986
28. Frayling TM, Hattersley AT, McCarthy A, Holly J, Mitchell SM, Gloyn AL et al (2002) A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations. Diabetes 51(7):2313-2316. doi:10.2337/diabetes.51.7.2313
29. Nam SY, Marcus C (2000) Growth hormone and adipocyte function in obesity. Horm Res 53(Suppl 1):87-97. doi:10.1159/ 000053211
30. Hadsell DL (2003) The insulin-like growth factor system in normal mammary gland function. Breast Dis 17:3-14
31. Slattery ML, Baumgartner KB, Byers T, Guiliano A, Sweeney C, Herrick J et al (2005) Genetic, anthropometric, and lifestyle factors associated with IGF-1 and IGFBP-3 levels in Hispanic and non-Hispanic white women. Cancer Causes Control 16(10):1147-1157. doi:10.1007/s10552-005-0318-2
32. Jernstrom H, Deal C, Wilkin F, Chu W, Tao Y, Majeed N et al (2001) Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev 10(4):377-384
33. Al-Zahrani A, Sandhu MS, Luben RN, Thompson D, Baynes C, Pooley KA et al (2005) IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Hum Mol Genet 15(1):1-10. doi:10.1093/hmg/ ddi398
34. Patel AV, Cheng I, Canzian F, Le Marchand L, Thun MJ, Berg CD et al (2008) IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer fisk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). PLoS One 3(7):e2578. doi:10.1371/journal.pone. 0002578
35. Johansson M, McKay JD, Wiklund F, Rinaldi S, Verheus M, van Gils CH et al (2007) Implications for prostate cancer of insulinlike growth factor-I (IGF-I) genetic variation and circulating IGF-I levels. J Clin Endocrinol Metab 92(12):4820-4826. doi:10.1210/jc.2007-0887
36. Diorio C, Brisson J, Berube S, Pollak M (2008) Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels. Cancer Epidemiol Biomarkers Prev 17(4):880-888. doi:10.1158/ 1055-9965.EPI-07-2500
37. Verheus M, McKay JD, Kaaks R, Canzian F, Biessy C, Johansson M (2007) Common genetic variation in the IGF-1 gene, serum IGF-I levels and breast density. Breast Cancer Res Treat. doi:10.1007/s10549-007
38. Canzian F, McKay JD, Cleveland RJ, Dossus L, Biessy C, Rinaldi S et al (2006) Polymorphisms of genes coding for insulinlike growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. Br J Cancer 94(2):299-307. doi:10.1038/ sj.bjc.6602936
39. Palles C, Johnson N, Coupland B, Taylor C, Carvajal J, Holly J et al (2008) Identification of genetic variants that influence circulating IGF1 levels: a targeted search strategy. Hum Mol Genet 17(10):1457-1464. doi:10.1093/hmg/ddn034
40. Voorhoeve PG, van Rossum EF, Te Velde SJ, Koper JW, Kemper HC, Lamberts SW et al (2006) Association between an IGF-I gene polymorphism and body fatness: differences between generations. Eur J Endocrinol 154(3):379-388. doi:10.1530/eje.1.02101
41. Sweeney C, Murtaugh MA, Baumgartner KB, Byers T, Giuliano AR, Herrick JS et al (2005) Insulin-like growth factor pathway polymorphisms associated with body size in Hispanic and non-Hispanic white women. Cancer Epidemiol Biomarkers Prev 14(7):1802-1809. doi:10.1158/1055-9965.EPI-05-0149
42. Sun G, Gagnon J, Chagnon YC, Perusse L, Despres JP, Leon AS et al (1999) Association and linkage between an insulin-like growth factor-1 gene polymorphism and fat free mass in the HERITAGE Family Study. Int J Obes Relat Metab Disord 23(9):929-935. doi:10.1038/sj.ijo.0801021
43. Lopez-Alarcon M, Hunter GR, Gower BA, Fernandez JR (2007) IGF-I polymorphism is associated with lean mass, exercise economy, and exercise performance among premenopausal women. Arch Med Res 38(1):56-63. doi:10.1016/j.arcmed.2006. 07.002
44. Tamimi RM, Cox DG, Kraft P, Pollak MN, Haiman CA, Cheng I et al (2007) Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study. Breast Cancer Res 9(1):R18. doi:10.1186/bcr1655
45. Chen TM, Kuo PL, Hsu CH, Tsai SJ, Chen MJ, Lin CW et al (2007) Microsatellite in the 30 untranslated region of human fibroblast growth factor 9 (FGF9) gene exhibits pleiotropic effect on modulating FGF9 protein expression. Hum Mutat 28(1):98. doi:10.1002/humu.9471